By Denise Mann HealthDay Reporter MONDAY, Oct. 24, 2022 (HealthDay News) — For the millions of people who live with vitiligo, a disease that robs the skin of its natural color, a newly approved cream called ruxolitinib (Opzelura) is quickly becoming a game changer. The U.S. Food and Drug Administration approved ruxolitinib for vitiligo in …
Continue reading “Cream May Restore Skin Pigmentation in People With Vitiligo”